---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-023003"
form_type: "8-K"
ticker: "OWLT"
cik: "0001816708"
company_name: "Owlet, Inc."
filed_at: "2023-06-22T23:59:59+00:00"
generated_at: "2026-06-13T19:15:45.164649+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Owlet receives FDA clearance for BabySat pulse-ox; NYSE commences warrant delisting

## Summary
- FDA cleared BabySat, first medical pulse-ox device with wire-free sock design; US launch expected later in 2023.
- NYSE halted trading in Owlet warrants (OWLT.WS) due to low price; moves to delist citing 'abnormally low' price levels.
- Company will not appeal warrant delisting; common stock (OWLT) trading on NYSE unaffected.

## SEC filing metadata
- accession: 0001628280-23-023003
- form_type: 8-K
- ticker: OWLT
- cik: 0001816708
- company_name: Owlet, Inc.
- filed_at: 2023-06-22T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816708/000162828023023003/0001628280-23-023003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816708/000162828023023003/owlt-20230615.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-023003
- JSON: https://secwatch.observer/filing/0001628280-23-023003.json
- Plain text: https://secwatch.observer/filing/0001628280-23-023003.txt

## Key facts
- Listing & Compliance Notices
  Owlet, Inc. received a nyse delisting notice notice regarding other (rules 802.01D).
  - Exchange: nyse
  - Notice: delisting notice
  - Rules: 802.01D
  source text: Warrants. On June 16, 2023, the NYSE provided written notice to the Company and publicly announced that NYSE Regulation has determined to commence proceedings to delist the Warrants and that the Warrants are no longer suitable for listing based on “abnormally low” price levels, pursuant to Section 802.01D of the NYSE Listed Company Manual. To effect the delisting, the NYSE will apply to the Securities and Exchange Commission to delist the Warrants pending completion of applicable procedures. The Company does not intend to appeal the NYSE’s determination. Trading in the Company’s Class A commo
  evidence_url: https://www.sec.gov/Archives/edgar/data/1816708/000162828023023003/0001628280-23-023003-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.